ConductScience.org, home

Paper16620142

Advances in the treatment of testicular cancer.

Kopp HG and 7 others. Drugs, 2006. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Advances in the treatment of testicular cancer. Papers, record 16620142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16620142

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances in the treatment of testicular cancer.
PubMed
Journal
Drugs
PubMed
Year
2006
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.05
iCite
Revised in PubMed
2022-03-18
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kopp HGHans-Georg
2Kuczyk MMarkus
3Classen JJohannes
4Stenzl AArnulf
5Kanz LLothar
6Mayer FFrank
7Bamberg MMichael
8Hartmann JTJörg Thomas

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
SeminomaMajor topic
Testicular NeoplasmsMajor topic
Brain Neoplasms
Combined Modality Therapy
Humans
Liver Neoplasms
Male
Neoplasm Staging
Orchiectomy
Prognosis
Salvage Therapy

Source PubMed

Download CSV of topics

References150

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112610187Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.J Clin Oncol2003https://conductscience.org/library/papers/12610187PubMed
29315391The International Germ Cell Consensus Classification: a new prognostic factor-based staging classification for metastatic germ cell tumours.Clin Oncol (R Coll Radiol)1997https://conductscience.org/library/papers/9315391PubMed
312686815
Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
J Urol2003https://conductscience.org/library/papers/12686815PubMed
48874322High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.J Clin Oncol1996https://conductscience.org/library/papers/8874322PubMed
59666776Surgery as salvage therapy in chemotherapy-resistant nonseminomatous germ cell tumours.Br J Urol1998https://conductscience.org/library/papers/9666776PubMed
69093705Residual mass following chemotherapy of seminoma.Ann Oncol1997https://conductscience.org/library/papers/9093705PubMed
79072586Surgery for a post-chemotherapy residual mass in seminoma.J Urol1997https://conductscience.org/library/papers/9072586PubMed
815738984Testicular germ-cell tumours in a broader perspective.Nat Rev Cancer2005https://conductscience.org/library/papers/15738984PubMed
912796024Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma.Ann Oncol2003https://conductscience.org/library/papers/12796024PubMed
1011956262Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.J Clin Oncol2002https://conductscience.org/library/papers/11956262PubMed
119081388Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.Ann Oncol1996https://conductscience.org/library/papers/9081388PubMed
1211283931Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.Cancer2001https://conductscience.org/library/papers/11283931PubMed
132439660The treatment of advanced metastatic seminoma: experience in 55 cases.J Clin Oncol1987https://conductscience.org/library/papers/2439660PubMed
147666083Stage I testicular seminoma: results of adjuvant irradiation and surveillance.J Clin Oncol1995https://conductscience.org/library/papers/7666083PubMed
152297486Long-term somatic side-effects and morbidity in testicular cancer patients.Br J Cancer1990https://conductscience.org/library/papers/2297486PubMed
1610080592Phase II trial of gemcitabine in refractory germ cell tumors.J Clin Oncol1999https://conductscience.org/library/papers/10080592PubMed
178605273Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy.Ann Hematol1996https://conductscience.org/library/papers/8605273PubMed
182419524Prognostic factors for favorable outcome in disseminated germ cell tumors.J Clin Oncol1986https://conductscience.org/library/papers/2419524PubMed
1910764433Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.J Clin Oncol2000https://conductscience.org/library/papers/10764433PubMed
2012697875Cardiovascular disease as a long-term complication of treatment for testicular cancer.J Clin Oncol2003https://conductscience.org/library/papers/12697875PubMed

See all 150 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
41844740CHD1L promotes testicular cancer progression through epigenetic activation of the CXCR6/PI3K/AKT pathway.Sci Rep2026https://conductscience.org/library/papers/41844740PubMed
41782041Severe multiorgan toxicities after the first cycle of standard-dose etoposide-cisplatin therapy for metastatic nonseminoma successfully managed with etoposide-carboplatin: a case report.J Med Case Rep2026https://conductscience.org/library/papers/41782041PubMed
40943467Medical Ozone Treatment Attenuates Male Reproductive Toxicity Induced by Bleomycin, Etoposide, and Cisplatin Regimen in an Experimental Animal Model.Int J Mol Sci2025https://conductscience.org/library/papers/40943467PubMed
38261810The ERF transcription factor LTF1 activates DIR1 to control stereoselective synthesis of antiviral lignans and stress defense in Isatis indigotica roots.Acta Pharm Sin B2024https://conductscience.org/library/papers/38261810PubMed
35488095Tissue-resident immunity in the female and male reproductive tract.Semin Immunopathol2022https://conductscience.org/library/papers/35488095PubMed
32857912METTL3 potentiates resistance to cisplatin through m6 A modification of TFAP2C in seminoma.J Cell Mol Med2020https://conductscience.org/library/papers/32857912PubMed
31906898Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.BMC Cancer2020https://conductscience.org/library/papers/31906898PubMed
30870501Clonal analyses of refractory testicular germ cell tumors.PLoS One2019https://conductscience.org/library/papers/30870501PubMed
30123998Effect of Zinc on Spermatogenesis and Sperm Chromatin Condensation in Bleomycin, Etoposide, Cisplatin Treated Rats.Cell J2019https://conductscience.org/library/papers/30123998PubMed
29789926Patterns of platinum drug use in an acute care setting: a retrospective study.J Cancer Res Clin Oncol2018https://conductscience.org/library/papers/29789926PubMed
28382315Supervised classification of etoposide-treated in vitro adherent cells based on noninvasive imaging morphology.J Med Imaging (Bellingham)2017https://conductscience.org/library/papers/28382315PubMed
27733284
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
Lancet2016https://conductscience.org/library/papers/27733284PubMed
26911428The Effects of Chemotherapeutic Agents, Bleomycin, Etoposide, and Cisplatin, on Chromatin Remodeling in Male Rat Germ Cells.Biol Reprod2016https://conductscience.org/library/papers/26911428PubMed
24829158The ganglioside GM3 is associated with cisplatin-induced apoptosis in human colon cancer cells.PLoS One2014https://conductscience.org/library/papers/24829158PubMed
23955676Iatrogenic genetic damage of spermatozoa.Adv Exp Med Biol2014https://conductscience.org/library/papers/23955676PubMed
22402960Exposure to bleomycin, etoposide, and cis-platinum alters rat sperm chromatin integrity and sperm head protein profile.Biol Reprod2012https://conductscience.org/library/papers/22402960PubMed
22242071Chemotherapy induced Hyponatraemia.BMJ Case Rep2010https://conductscience.org/library/papers/22242071PubMed
19680688Posttreatment surveillance after paraaortic radiotherapy for stage I seminoma: a systematic analysis.J Cancer Res Clin Oncol2010https://conductscience.org/library/papers/19680688PubMed
19089452Identification of genomic regions contributing to etoposide-induced cytotoxicity.Hum Genet2009https://conductscience.org/library/papers/19089452PubMed
18987330Impact of the chemotherapy cocktail used to treat testicular cancer on the gene expression profile of germ cells from male Brown-Norway rats.Biol Reprod2009https://conductscience.org/library/papers/18987330PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16620142

GET https://conductscience.org/api/papers/v1/16620142/references?page=2